---
title: "Bio-Rad to Participate in Upcoming Investor Conferences | BIO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285732039.md"
description: "Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) announced its participation in two upcoming investor conferences. The first is the RBC Capital Markets Global Healthcare Conference on May 19, 2026, featuring CFO Roop K. Lakkaraju. The second is the Jefferies 2026 Global Healthcare Conference on June 3, 2026, also with CFO Lakkaraju. Both events will include fireside chats and one-on-one meetings, with webcasts available on Bio-Rad's Investor Relations website."
datetime: "2026-05-08T05:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285732039.md)
  - [en](https://longbridge.com/en/news/285732039.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285732039.md)
---

# Bio-Rad to Participate in Upcoming Investor Conferences | BIO Stock News

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences:

**2026 RBC Capital Markets Global Healthcare Conference  
**Format: Fireside chat and one-on-one investor meetings  
Participants: Roop K. Lakkaraju, Chief Financial Officer  
Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live webcast and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com

**Jefferies 2026 Global Healthcare Conference  
**Format: Fireside chat and one-on-one investor meetings  
Participants: Roop K. Lakkaraju, Chief Financial Officer  
Date and Time: Wednesday, June 3, 2026 at 8:45 AM Eastern Time; a live webcast and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com

**About Bio-Rad**

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 7,400 employees, and $2.6 billion in revenues in 2025. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260508350759/en/

**Investor Contact:**  
Ruben Argueta, Investor Relations  
510-741-6104  
ir@bio-rad.com

**Media Contact:**  
Anna Gralinska, Corporate Communications  
510-741-6643  
cc@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

### Related Stocks

- [BIO.US](https://longbridge.com/en/quote/BIO.US.md)
- [BIO.B.US](https://longbridge.com/en/quote/BIO.B.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)

## Related News & Research

- [Market Chatter: Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround](https://longbridge.com/en/news/286739881.md)
- [Activist Elliott Takes Major Stake in Bio-Rad — Can It Boost BIO Stock Price?](https://longbridge.com/en/news/286737807.md)
- [Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports](https://longbridge.com/en/news/286690023.md)
- [VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME | VBIO Stock News](https://longbridge.com/en/news/286964504.md)
- [Bio-Rad Laboratories (NYSE:BIO.B) Sees Strong Trading Volume  - Should You Buy?](https://longbridge.com/en/news/285750935.md)